I guess you are correct. If the CE announcement is regarded as price sensitive then any substantive info given to the company about how certification is going must also be released under the continuous disclosure obligation. Sleep apnea was not price sensitive so no obligation to disclose progress. IMO and DYOR
- Forums
- ASX - By Stock
- RAP
- Telehealth on the rise
Telehealth on the rise, page-830
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 2,245 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online